Pinpoint healing for infected cells
The SARS-CoV2-pandemic has raised our awareness of the specific needs of groups that face greater risks from the virus. Autoimmune diseases affect 5-8 percent of the population. At Potsdam Science Park, Rodos Biotarget GmbH is getting closer to an innovative new treatment approach for pinpoint healing of infected cells.
Read more